Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose prednisone for PTSD
NCT00204737Phase 4Completed
- Sponsor
- University of Wisconsin–Madison
- Start
- Dec 2004
- Primary completion
- Jan 2009
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in post-traumatic stress disorder (PTSD) comparing Prednisone with Placebo (2 arms). Primary endpoints: Clinician-Administered PTSD Scale at 12 weeks and Clinician-Administered PTSD Scale Response at 12 weeks. Started Dec 2004; status: completed.
02
Drugs
prednisone
03
Conditions
post-traumatic stress disorder (PTSD)
Beyond the preview
Go deeper on NCT00204737.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00204737.